Recent mRNA manufacturing capacity shifts highlight why raw material strategy matters. This guide covers GMP-grade IVT enzymes, capping, DNase cleanup, QC and OEM planning for resilient RNA programs.
Biopharma QC
CareDx’s Naveris acquisition highlights rising interest in cfDNA MRD testing. This guide explains reagent, assay QC, sample prep and OEM considerations for molecular diagnostics teams.
A practical guide to residual DNA testing in gene therapy and biomanufacturing QC, covering method selection, sample prep, HCP/HCD risk, and supplier considerations.
Meet Biori at ASGCT 2026, Booth No. 1511, to discuss HCD/HCP testing solutions, universal nuclease, and customized kit development services for CGT manufacturing and QC.
Biori will attend BIO KOREA 2026 in Seoul from April 28–30. Visit us at Booth L13 to discuss IVD raw materials, PCR, NGS, IVT, OEM, and biopharma QC solutions.
Explore the mRNA bird flu vaccine workflow, from GMP-grade IVT enzymes and capping to residual DNA and HCP testing for biopharma QC.
